Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis
- 1 September 2007
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 78 (9) , 970-974
Abstract
Introduction: Neurocysticercosis (NC), a parasitic disease caused by Taenia solium, may be either asymptomatic or show a mild to severe clinical picture with intracranial hypertension. The most severe form of the disease is caused when viable cysticerci are localised in the ventricles or in subarachnoidal cisterns at the base of the skull. Detection of the secreted metacestode antigen HP10 in cerebrospinal fluid is a sensitive and specific method for the diagnosis of these severe NC cases. Objective and methods: To evaluate the validity of HP10 antigen detection ELISA when applied to serum, using paired serum and cerebrospinal fluid samples from 116 radiologically and clinically characterised NC patients. Results: The HP10 antigen assay exhibited a similarly high sensitivity in identifying severe NC cases from sera (84.8%) and CSF (91.3%). In contrast, HP10 antigen was rarely detected in asymptomatic or mild NC cases (3 of 57). Importantly, the HP10 antigen assay applied to serum showed high specificity (94%) when used in 126 serum samples of non-NC subjects from an endemic community with a confirmed coproparasitological diagnosis of intestinal parasitic infections. Finally, the HP10 assay also proved to be of value in the follow-up of treated patients. Conclusion: This study confirms that detection of the metacestode HP10 antigen in serum is a useful tool for diagnosis and follow-up of patients with severe forms of NC treated with cysticidal drugs.Keywords
This publication has 18 references indexed in Scilit:
- Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow‐upTropical Medicine & International Health, 2006
- An epidemiological study of familial neurocysticercosis in an endemic Mexican communityTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosisNeurology, 2006
- Detection of muscle calcifications by thigh CT scan in neurocysticercosis patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 2005
- Ag-ELISA and PCR for Monitoring the Vaccination of Cattle against Taenia saginata Cysticercosis Using an Oncospheral Adhesion Protein (HP6) with Surface and Secreted LocalizationTropical Animal Health and Production, 2005
- Symptomatic human neurocysticercosisJournal of Neurology, 2004
- High Prevalence of Calcified Silent Neurocysticercosis in a Rural Village of MexicoNeuroepidemiology, 2003
- Diagnosis of porcine cysticercosis: a comparative study of serological tests for detection of circulating antibody and viable parasitesVeterinary Parasitology, 1998
- Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluidTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- An Enzyme-Linked Immunoelectrotransfer Blot Assay and Glycoprotein Antigens for Diagnosing Human Cysticercosis (Taenia solium)The Journal of Infectious Diseases, 1989